Log in to save to my catalogue

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7502749

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

About this item

Full title

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-09, Vol.117 (37), p.23106-23112

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Thalidomide exerts its teratogenic and immunomodulatory effects by binding to cereblon (CRBN) and thereby inhibiting/modifying the CRBN-mediated ubiquitination pathway consisting of the Cullin4-DDB1-ROC1 E3 ligase complex. The mechanism of thalidomide’s classical hypnotic effect remains largely unexplored, however. Here we examined whether CRBN is...

Alternative Titles

Full title

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7502749

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7502749

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1917701117

How to access this item